Alex Philippidis
alexwestchester.bsky.social
Alex Philippidis
@alexwestchester.bsky.social
Senior Business Editor, Genetic Engineering & Biotechnology News, GEN Edge, and Mary Ann Liebert Inc., New Rochelle, NY. http://genengnews.com
Pinned
6May: What personal stories and policy recommendations did cell and gene therapy leaders share with officials from the @fda.gov, NIH, CMS, and HHS? Colleague and editor @kevinadavies.bsky.social and I recap Thursday's historic FDA roundtable in GEN: www.genengnews.com/topics/genom...
Cell and Gene Therapy Leaders Tell FDA: “Believe in American Solutions”
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top offi...
www.genengnews.com
6August: How does Ocugen ( $OCGN ) expect OCU410 to stand out among geographic atrophy treatments when two such drugs have entered the market in recent years, bolstered by saturation ad campaigns? Hear from CEO Shankar Musunuri, PhD, in my latest for GEN: www.genengnews.com/topics/genom...
3 BLAs in 3 Years: Ocugen Sees Potential in Eye Disease Gene Therapies
Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by working to bring to market three treatments for blindness-related diseases, two ...
www.genengnews.com
August 10, 2025 at 5:22 AM
6May: What personal stories and policy recommendations did cell and gene therapy leaders share with officials from the @fda.gov, NIH, CMS, and HHS? Colleague and editor @kevinadavies.bsky.social and I recap Thursday's historic FDA roundtable in GEN: www.genengnews.com/topics/genom...
Cell and Gene Therapy Leaders Tell FDA: “Believe in American Solutions”
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top offi...
www.genengnews.com
June 6, 2025 at 5:40 AM
19May: What is Illumina demanding of Element Biosciences in a patent infringement lawsuit filed Thursday? And how is Element responding? One of my latest for GEN: www.genengnews.com/topics/omics...
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents
Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are reviewing the complaint and look forward to defending our innovations in cou...
www.genengnews.com
May 20, 2025 at 2:10 PM
Reposted by Alex Philippidis
Giving away translations of some of my books — please get in touch if interest:

- Breakthrough (1995) 🇬🇧
- Cracking the Genome (2001) 🇯🇵🇵🇹🇪🇸🇳🇱🇨🇿🇩🇪🇸🇪🇮🇹🇸🇦
- The $1,000 Genome (2010) 🇰🇷🇧🇷
- Editing Humanity (2020) 🇰🇷🇷🇺🇯🇵🇮🇹
May 3, 2025 at 12:08 PM
27April: Thanks to BioHealth Innovation's Rich Bendis and his BioTalk podcast for inviting me back to discuss the convulsive policy shifts and resulting impacts on biotech business and investment activity. Listen here or wherever you get podcasts: www.youtube.com/watch?v=nft8...
BioHealth at a Crossroads: Alex Philippidis on Policy Shifts, Investment Trends, and What’s Ahead
YouTube video by BioHealth Innovation, Inc.
www.youtube.com
April 27, 2025 at 5:52 PM
2April: Rounding up the darkest day for the federal agencies at the center of #biotech ... My latest for GEN:
www.genengnews.com/topics/drug-...
FDA, NIH, CDC Stagger as HHS Axe Falls, Eliminating 10,000 Jobs
The 10,000 jobs being eliminated include 3,500 positions at the FDA, 2,400 at the U.S. Centers for Disease Control and Prevention (CDC), and 1,200 at the NIH.
www.genengnews.com
April 2, 2025 at 5:19 AM
31March: Will Trump's planned tariffs return biopharma manufacturing to the U.S.? Which companies did Jefferies say were most and least exposed if these tariffs take effect? Also, updates on $ATNA, $SAVA, $EQ, & $MURA in my latest StockWatch for GEN: www.genengnews.com/topics/biopr...
StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.?
With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry leaders, market watchers, and others have begun assessing which companies will ...
www.genengnews.com
March 31, 2025 at 1:42 PM
31March: How have #biotech industry groups, an analyst, some research leaders and others addressed the surprising departure of Peter Marks, MD, from the FDA? Colleague and editor @kevinadavies.bsky.social and I summed up the responses for GEN: www.genengnews.com/topics/drug-...
Industry Voices Alarm as Peter Marks Departs FDA
The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.
www.genengnews.com
March 31, 2025 at 5:26 AM
31March: Howdy BlueSky... The plural of which is Blue Skies. Ella can take it from here....
www.youtube.com/watch?v=SAa4...
Blue Skies
YouTube video by Ella Fitzgerald - Topic
www.youtube.com
March 31, 2025 at 5:23 AM